Pancreatic Cancer Research

ResearcherThe University of SydneyActive in the last 2 years

James G. Kench

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8687-4988; OpenAlex author ID A5086908096. Sources: OpenAlex.

Their work

Papers
25 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
57
Papers, trials and grants by year

2011: 3 papers · 2012: 2 papers · 2013: none · 2014: 2 papers · 2015: 2 papers · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: 3 papers · 2020: 2 papers · 2021: 1 paper · 2022: 3 papers · 2023: 1 paper · 2024: none · 2025: 3 papers

Papers 25

  1. Aiming for high quality of care for completed resections and improved margin status in pancreatic cancer surgery. Co-author DOI 10.1016/j.pan.2025.09.029↗
  2. C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients. Co-author DOI 10.1111/ajco.13993↗
  3. Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification. Co-author DOI 10.1158/2767-9764.crc-25-0229↗
  4. A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer. Co-author DOI 10.1038/s43018-023-00614-y↗
  5. The association between quality care and outcomes for a real-world population of Australian patients diagnosed with pancreatic cancer. Co-author DOI 10.1016/j.hpb.2021.11.005↗
  6. Prognostic models to predict survival in patients with pancreatic cancer: a systematic review. Co-author DOI 10.1016/j.hpb.2022.01.011↗
  7. Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence. Co-author DOI 10.1053/j.gastro.2021.09.022↗
  8. ROR1 and ROR2 expression in pancreatic cancer. Co-author DOI 10.1186/s12885-021-08952-9↗
  9. Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer. Co-author DOI 10.1097/sla.0000000000003143↗
  10. Barriers and enablers to the implementation of protocol-based imaging in pancreatic cancer: A qualitative study using the theoretical domains framework. Co-author DOI 10.1371/journal.pone.0243312↗
  11. Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus. Co-author DOI 10.1016/j.hpb.2018.08.016↗
  12. CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan. Co-author DOI 10.1038/s41467-019-10968-6↗
  13. Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma. Co-author DOI 10.1136/gutjnl-2018-316595↗
  14. Hypermutation In Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2016.09.060↗
  15. Genomic analyses identify molecular subtypes of pancreatic cancer. Co-author DOI 10.1038/nature16965↗
  16. Refining the care of patients with pancreatic cancer: the AGITG Pancreatic Cancer Workshop consensus. Co-author DOI 10.5694/mja16.00061↗
  17. Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. Co-author DOI 10.1002/bjs.9892↗
  18. Whole genomes redefine the mutational landscape of pancreatic cancer. Co-author DOI 10.1038/nature14169↗
  19. Clinical and pathologic features of familial pancreatic cancer. Co-author DOI 10.1002/cncr.28863↗
  20. Adjuvant chemotherapy in elderly patients with pancreatic cancer. Co-author DOI 10.1038/bjc.2013.722↗
  21. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Co-author DOI 10.1038/nature11547↗
  22. The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Co-author DOI 10.1093/annonc/mdr561↗
  23. Precursor lesions in pancreatic cancer: morphological and molecular pathology. Last author DOI 10.1097/pat.0b013e3283445e3a↗
  24. Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interaction. Co-author DOI 10.1371/journal.pone.0026088↗
  25. Retinoid signaling in pancreatic cancer, injury and regeneration. Co-author DOI 10.1371/journal.pone.0029075↗

Closest collaborators

The 25 strongest of 57 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Neil Donald Merrett · 8 shared papers, 2012–2025 · strength 0.75
  2. Rachel Ε. Neale · 5 shared papers, 2019–2025 · strength 0.61
  3. Ashika D. Maharaj · 5 shared papers, 2019–2025 · strength 0.61
  4. John Raymond Zalcberg · 5 shared papers, 2019–2025 · strength 0.61
  5. Liane Ioannou · 5 shared papers, 2019–2025 · strength 0.61
  6. Charles H. C. Pilgrim · 5 shared papers, 2019–2025 · strength 0.61
  7. Sue Evans · 5 shared papers, 2019–2025 · strength 0.61
  8. Kate White · 5 shared papers, 2019–2025 · strength 0.61
  9. Daniel Gerald Croagh · 5 shared papers, 2019–2025 · strength 0.61
  10. Jaswinder Singh Samra · 8 shared papers, 2012–2025 · strength 0.55
  11. David Goldstein · 5 shared papers, 2015–2025 · strength 0.48
  12. David Goldstein · 3 shared papers, 2022–2025 · strength 0.45
  13. Koroush Shahsavar Haghighi · 3 shared papers, 2016–2025 · strength 0.34
  14. Andrew P. Barbour · 3 shared papers, 2015–2025 · strength 0.32
  15. Jennifer A. M. Philip · 3 shared papers, 2019–2022 · strength 0.27
  16. Val Gebski · 2 shared papers, 2015–2025 · strength 0.26
  17. Andrew Victor Biankin · 7 shared papers, 2011–2020 · strength 0.24
  18. Elizabeth A. Burmeister · 2 shared papers, 2022 · strength 0.24
  19. Mehrdad Nikfarjam · 3 shared papers, 2016–2022 · strength 0.24
  20. Lorraine A. Chantrill · 5 shared papers, 2012–2020 · strength 0.23
  21. Christopher James Scarlett · 6 shared papers, 2011–2020 · strength 0.21
  22. Vanessa Bonazzi · 1 shared paper, 2025 · strength 0.21
  23. Anthony James Gill · 5 shared papers, 2012–2020 · strength 0.21
  24. David Kuang-Fu Chang · 6 shared papers, 2011–2020 · strength 0.21
  25. Trevor Leong · 2 shared papers, 2020–2022 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.